Navigation Links
Thomas Mac Mahon Joins SynapDx Corporation's Board of Directors
Date:4/25/2011

SOUTHBOROUGH, Mass., April 25, 2011 /PRNewswire/ -- SynapDx Corporation announced today that Thomas Mac Mahon has joined its board of directors.

Thomas Mac Mahon was President and Chief Executive Officer and a member of the Executive and Management Committees of Laboratory Corporation of America (LabCorp) from January 1997 until his retirement at the end of 2006. Prior to LabCorp, Mr. Mac Mahon was Senior Vice President of Hoffmann-La Roche Inc. (Roche) from 1993 to December 1996 and President of Roche Diagnostics Group from 1988 to December 1996.

Mr. Mac Mahon currently serves on the board of directors of LabCorp. He was Chairman of the Board of Directors of LabCorp from April 1996 until May 2009. He is currently a director of Express Scripts, Inc. and a member of the board of PharMerica Corporation.

About SynapDx Corporation

SynapDx's mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control.

SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures and General Catalyst Partners. SynapDx's corporate headquarters is located in Southborough, MA. For more information, please visit: www.synapdx.com.


'/>"/>
SOURCE SynapDx Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Thomas Wessling and Julie Wright Join Performance Plus Marketing
2. Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
3. Solta Medical, Inc. Appoints Thomas J. Yorkey, Ph.D. to Vice President of Research & Development
4. Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer
5. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
6. Osteotechs Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council
7. MAP Pharmaceuticals Appoints Thomas P. McCracken as Vice President, Intellectual Property
8. Excaliard Pharmaceuticals Appoints Thomas Wiggans to Chairman of the Board
9. Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimers Disease
10. K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
11. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/17/2017)...  MedX Holdings, Inc., the manufacturer and global distributor ... equipment, today announced the national roll out of its ... gold standard for the treatment of low back injuries ... How it works: ... practice who prescribe the MedX Home Back Machine Program ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... July 28, 2017 , ... ... upcoming episode of the award-winning television series, American Famer, scheduled to broadcast fourth ... , Syngenta is dedicated to helping humanity face its toughest challenge: how to ...
(Date:7/27/2017)... ... July 27, 2017 , ... SSCI, a division ... 600 patent challenges worldwide, representing a milestone achievement. , As an ... development, SSCI scientists have served as expert and fact witnesses to assist our ...
(Date:7/27/2017)... , ... July 27, 2017 , ... Healthy eating isn’t always easy. Currently, more than ... the same time, many Americans overeat refined grains and sugar. This trend may help explain ... adults in the U.S. are obese. , As a culture, we seem to have food ...
(Date:7/27/2017)... ... July 27, 2017 , ... Team Novo Nordisk, the world’s first all-diabetes ... pro squad as a stagiaire for the remainder of the 2017 season. One of ... 31st at the Tour of Utah. , “Every season we are excited to move ...
(Date:7/26/2017)... ... 2017 , ... An inventor from Salisbury, N.C., knows the difficulties involved with ... and dignified way to keep leeches in place during therapy," she said. "That’s why ... an effective way to keep a leech in place on the skin during therapy. ...
Breaking Medicine News(10 mins):